(MENAFNEditorial)
Nausea and vomiting that can be caused by many conditions. Common causes include motion sickness self-limited illnesses that last a few hours to a few days and toxins. Antiemetics drugs are typically used to treat motion sickness and the side effects of opioid analgesics general anaesthetics and chemotherapy directed against cancer. Various types of antiemetics can decrease the severity of nausea although most require a medical evaluation and prescription.
Increasing incidences of various types of cancer along with the side effects of chemotherapy is major key factor of . Additionally increasing prevalence of lifestyle induced diseases expected to boost demand for antiemetic drugs during the forecast period. Moreover introduction technologically advanced drug delivery and rising awareness regarding clinical benefits anticipated to grow significantly during the forecast period. However lack of suitable animal model to imitate the human responses to antiemetic therapy hampers the market growth.
Read More @
The antiemetic drug market is segmented on the basis of type application and geography. On the basis of class is segmented into as 5-HT3 receptor antagonists dopamine antagonists NK1 receptor antagonist antihistamines cannabinoids and others. 5-HT3 antagonist segment expected to witness significant growth over the forecast period. On the basis of application the market has been segmented into chemotherapy motion sickness gastroenteritis general anesthetics opioid analgesics dizziness pregnancy food poisoning emotional stress and others. Chemotherapy is leading application segment of antiemetic drug market.
The regional segmentation includes the current and forecast demand for North America Europe Asia Pacific Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany France UK China Japan India and Brazil. North America and Europe are dominated regions for antiemetic drug market. With increasing population and incidences of gastroenteritis diseases in the Asia Pacific region has boost up the demand for antiemetic drug and expected to fuel market growth in this region.
The report covers forecast and analysis for the antiemetic drug market on a global and regional level. The report provides comprehensive view on the antiemetic drug market study included a detailed competitive scenario and product portfolio of key vendors. The report analyzes the attractiveness of segments. Additionally the study analyzes market competition and industry players using Porter’s five forces analysis.
Some of the key players operating in antiemetic drug market include Pfizer GlaxoSmithCline Merck Sanofi-Aventis Bristol-Myers Squibb Eli Lilly and Company Astellas Pharma Johnson & Johnson and Baxter International
Access sample report visit at
This report segments the global antiemetic drug market as follows:
Antiemetic Drug Market: Type Segment Analysis
5-HT3 Receptor Antagonists
Dopamine Antagonists
NK1 Receptor Antagonist
Antihistamines
Cannabinoids
Others
Antiemetic Drug Market: Application Segment Analysis
Chemotherapy
Motion Sickness
Gastroenteritis
General Anesthetics
Opioid Analgesics
Dizziness
Pregnancy
Food Poisoning
Emotional Stress
Others
Antiemetic Drug Market: Regional Segment Analysis
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East & Africa
Inquiry for buying report visit at
Contact US:
Joel John
3422 SW 15 StreetSuit #8138
Deerfield BeachFlorida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email:
Website:
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.